BD has expanded a Class I Alaris recall to cover 15 additional pump infusion sets, the company said Friday. The Food and Drug Administration posted the company's notice on Monday. The company added ...

The Syndeo pump could be reintroduced after Baxter fixes its design problems. CDRH has historically been suspicious about the reliability of infusion pumps. Incidents with two pump makers in 2006 have ...

BD will pay a $175 million civil penalty to settle charges from the Securities and Exchange Commission that the company misled investors about problems with its Alaris infusion pumps. The SEC issued a ...

A new group of recalls for a repair piece installed in some of BD’s Alaris infusion pumps joins more than a dozen others on the long list of serious recalls involving the device in the last decade.

To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued a voluntary recall related to certain Alaris™ and BD Alaris™ Pump Modules that may have been ...

Dec 1 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson BDX.N is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health's CAH.N ...

Feb 6 (Reuters) - Cardinal Health Inc. said it reached an agreement with the U.S. Food and Drug Administration on a consent decree regarding its Alaris infusion pumps. The agreement, which is subject ...

Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device ...

Dec 1 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson (BDX.N), opens new tab is recalling its Alaris infusion pumps due to compatibility issues with ...